Immunohistochemistry Market, By Product (Antibodies, Reagents, Equipment, and Kits), By Application (Diagnostics, Research, and Others), By End User (Hospitals, Diagnostics Laboratories, Academic & Research Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Mar 2024

Code : CMI4795

Pages :142

Formats :

Excel and PDF

Industry : Pharmaceutical

Market Challenges: Development of alternative diagnostics techniques

The immunohistochemistry market faces several challenges. Technological advancement in pathology diagnostics has allowed for new techniques like in-situ hybridization to emerge, providing alternatives to IHC. Stringent regulations surrounding tissue sample handling and antibody specificity require extensive validation. This increases costs and regulatory hurdles for new market entrants. Additionally, the high cost of instruments like automated stainers limits their adoption in low resource settings. Stringent reimbursement policies also impact the pricing and uptake of IHC tests in some countries.

Market Opportunities: Aging population prone to age-related diseases

The rising global incidence of cancer and other chronic diseases is driving increased demand for precision diagnostics using IHC biomarkers. Furthermore, an aging population prone to age-related diseases will require more diagnostic testing. Newly discovered protein biomarkers continue to expand the clinical applications of IHC. Automation and multiplex assays promise to increase throughput and lower turn thus, creating lucrative opportunities for market growth over the forecasted period.